Research programme: CNS disorders - Esteve/4SC
Alternative Names: CNS disorders research programmeLatest Information Update: 26 Apr 2006
At a glance
- Originator 4SC; Esteve
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 26 Apr 2006 No development reported - Preclinical for CNS disorders in Germany (unspecified route)
- 15 Jul 2003 Preclinical trials in CNS disorders in Germany (unspecified route)